Indocyanine Green

吲哚菁绿

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameIndocyanine Green
Drug Alias Name吲哚花青绿靛氰绿吲哚氰绿吲哚青绿靛花青绿 +[13] 
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsContrast agentsSkin MelanomaSolid tumours +[63] 
Global Approved IndicationsContrast agents
Approved Indications in ChinaContrast agents
Original Approved Country/TerritoryUnited States
Original Approved Date1959/02/09
Country/TerritoryBelgiumCanadaUnited States +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAkorn
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer InstituteUniversity Medical Center GroningenVPIX Medical Inc +[22] 
Inactive CompaniesNovadaq Technologies Ulc, Now A Part Of StrykerCardiox CorporationThe Brigham and Women's Hospital +[22] 
Active IndicationsContrast agentsSkin MelanomaSolid tumours +[34] 
Inactive IndicationsFractures, ComminutedSurgical Wound DehiscenceAnastomotic Leak +[29] 

Other Information

ATC CodeV04CX01
Related LinksWikipediaDrugBankKEGG